Tag:
CardioDx
Latest Headlines
Latest Headlines
Study: Corus CAD demonstrates superiority to MPI
CardioDx saw good news from Florida this week with the presentation of results from the COMPASS trial involving Corus CAD, a blood-based gene expression test for obstructive coronary artery disease.
CardioDx rounds out executive team
Palo Alto, CA-based CardioDx, a cardiovascular genomic diagnostics company, has made two recent hires: Andrew Guggenhime as its CFO and Mark Monane as CMO. The company had been waiting for the
GE Healthcare invests $5M in CardioDx
GE Healthcare has entered an alliance with CardioDx to co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease. Building on the alliance, the GE
